General Electric is far from stodgy. With a few forays into futuristic technology, this blue chip makes a great investment. Best of all? It's at a mega-discount today.

An analyst at Jeffries says that he is more confident of that happening for Stratasys, though maybe not as quickly as hoped, and more pessimistic for rival 3D Systems.

Johnson & Johnson, which began selling Baby Powder in 1894, will end all sales of the talc-based product next year.

Apple is asking assemblers to put together 220 million iPhones this year, Bloomberg reported, a tally that largely matches 2021 levels.

"The supply chain continues to be the limiting factor in our production rates but we remain confident in our ability to achieve our target," said CFO Claire McDonough.

DNA-sequencing leader Illumina swung to a loss in Q2 2022. Contributions from Grail didn't help.